doi:10.3969/j.issn.1673-8640.2026.02.018

Abstract

CLC Number:

R733.71

Figures/Tables 2

References 22

[1]	TESTI A M, MOHAMED S, DIVERIO D, et al. Outcome of relapsed/refractory acute promyelocytic leukaemia in children,adolescents and young adult patients:a 25-year Italian experience[J]. Br J Haematol, 2021, 195(2):278-283. DOI URL
[2]	AUTORE F, CHIUSOLO P, SORÀ F, et al. Efficacy and tolerability of first line arsenic trioxide in combination with all-trans retinoic acid in patients with acute promyelocytic leukemia:real life experience[J]. Front Oncol, 2021, 11:614721. DOI URL
[3]	GIRI S, PATHAK R, ARYAL M R, et al. Second primary malignancy in acute promyelocytic leukemia：a surveillance，epidemiology and end results database study[J]. Future Oncol, 2017, 13(17):1455-1457. DOI URL
[4]	LENZI L, LEE-JONES L, MOSTOFA M A, et al. Second primary malignancy after acute promyelocytic leukemia: a population-based study[J]. Cancers (Basel), 2020, 12(12):2610. DOI URL
[5]	GARCIA-MANERO G, KANTARJIAN H M, KORNBLAU S, et al. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia(APL)[J]. Leukemia, 2002, 16(9):1888.
[6]	LATAGLIATA R, PETTI M C, FENU S, et al. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia:an emerging problem[J]. Blood, 2002, 99(3):822-824. DOI URL
[7]	LOBE I, RIGAL-HUGUET F, VEKHOF A, et al. Myelodysplastic syndrome after acute promyelocytic leukaemia:the European APL group experience[J]. Leukemia, 2003, 17(8):1600-1604. DOI
[8]	MONTESINOS P, GONZÁLEZ J D, GONZÁLEZ J, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy[J]. J Clin Oncol, 2010, 28(24):3872-3879. DOI PMID
[9]	弓晓媛, 王迎, 刘兵城, 等. MLL基因重排成人急性髓系白血病的特征和预后分析[J]. 中华血液学杂志, 2018, 39(1):9-14.
[10]	YAMAMOTO K, SHIBATA F, YAMAGUCHI M, et al. Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia(M4) with t(11;17)(q23;q25)[J]. Int J Hematol, 2002, 75(5):503-507. DOI URL
[11]	SHIH L Y, LIANG D C, FU J F, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement[J]. Leukemia, 2006, 20(2):218-223. DOI
[12]	STREHL S, KÖNIG M, MEYER C, et al. Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants[J]. Genes Chromosomes Cancer, 2006, 45(11):1041-1049. DOI URL
[13]	KUROSU T, TSUJI K, OHKI M, et al. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia(M5b) with t(11;17)(q23;q25)[J]. Int J Hematol, 2008, 88(2):192-196. DOI URL
[14]	SAITO H, OTSUBO K, KAKIMOTO A, et al. Emergence of two unrelated clones in acute myeloid leukemia with MLL-SEPT9 fusion transcript[J]. Cancer Genet Cytogenet, 2010, 201(2):111-115. DOI URL
[15]	FORLENZA C J, ZHANG Y, YAO J, et al. A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia[J]. Cold Spring Harb Mol Case Stud, 2018, 4(6):a003426. DOI URL
[16]	KREUZIGER L M, PORCHER J C, KETTERLING R P, et al. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome[J]. Leuk Res, 2007, 31(8):1145-1148. DOI URL
[17]	柴国静, 南英博, 赵海利, 等. PML/RARα阳性APL缓解后继发PML/RARα阴性AML 1例报道[J]. 检验医学, 2023, 38(11):1106-1108. DOI
[18]	王哲, 徐梅珍, 陈云飞, 等. 急性早幼粒细胞白血病治疗相关性髓系肿瘤四例报告并文献复习[J]. 中华血液学杂志, 2019, 40(12):1008-1014.
[19]	GALE R P, BENNETT J M, HOFFMAN F O. Therapy-related AML:a slip of the lip can sink a ship[J]. Leuk Res, 2014, 38(3):418-420. DOI URL
[20]	FUJIKI A, IMAMURA T, FURUTANI A, et al. Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13)[J]. J Pediatr Hematol Oncol, 2012, 34(5):402-405. DOI URL
[21]	KAYSER S, DÖHNER K, KRAUTER J, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2 853 adult patients with newly diagnosed AML[J]. Blood, 2011, 117(7):2137-2145. DOI URL
[22]	BHATIA S. Therapy-related myelodysplasia and acute myeloid leukemia[J]. Semin Oncol, 2013, 40(6):666-675. DOI PMID

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 22

Related Articles 15

Recommended Articles

Metrics

[1]	. [J]. Laboratory Medicine, 2025, 40(10): 1025-1029.
[2]	LIU Min, SUN Hengjuan, DU Chengkan, XIA Min, JIANG Linlin, WENG Wenhao, ZHANG Hong. Laboratory analysis of 6 cases of acute megakaryocytic leukemia in children [J]. Laboratory Medicine, 2025, 40(5): 484-488.
[3]	LIU Mengna, WANG Hongling, BAI Ping, CAI Yu, LI Li. Research progress on laboratory diagnosis and treatment of ETP-ALL [J]. Laboratory Medicine, 2025, 40(1): 1-7.
[4]	DING Jing, ZHANG Chunling, WANG Xiaorui, LI Huidan, WANG Hongling, LIU Weiling, LIN Lihui, LI Li. Laboratory diagnosis and prognostic factor analysis of core binding factor-related acute myeloid leukemia [J]. Laboratory Medicine, 2024, 39(7): 673-681.
[5]	CHEN Yongwei, WANG Jing, YANG Xiaolong, HU Fangyu, LIN Fang. Applicability of CLSI EP09-A3 in 2-method comparison determining serum total triiodothyronine [J]. Laboratory Medicine, 2024, 39(2): 176-180.
[6]	. [J]. Laboratory Medicine, 2024, 39(1): 100-102.
[7]	. [J]. Laboratory Medicine, 2021, 36(12): 1292-1294.
[8]	. [J]. , 2007, 22(05): 574-577.
[9]	. [J]. , 2007, 22(02): 213-214.
[10]	. [J]. , 2006, 21(05): 533-536.
[11]	. [J]. , 2006, 21(04): 438-439.
[12]	. [J]. , 2006, 21(03): 254-258.
[13]	ZHANG Qiutang;LI Tao. Immunophenotyping of 201 adult patients with acute leukemia [J]. , 2005, 20(04): 373-375.
[14]	WU Jianguo;WU Mao;QIU Liannü;LIN Huijun;CHEN Zhimei;WANG Yungui. Report of a case of acute myeloid leukemia characterized by double t (8; 21 ) translocations [J]. , 2005, 20(02): 104-108.
[15]	. Study on the expression of ki-67 in acute leukemia [J]. , 2004, 19(06): 544-545.